Latest Communications

07 July 2010
MonoSol Rx Announces FDA Approval of Zuplenz® Oral Soluble Film for Treatment of Nausea and Vomiting

15 June 2010
APR Applied Pharma Research s.a. of Switzerland launches its new corporate website and announces key strategic changes in its Business Model to better compete in the rapidly changing Healthcare industry

09 June 2010
MonoSol Rx and APR Applied Pharma Research s.a. Expand Joint Collaboration Agreement to develop and commercialize film formulations of prescription products


Eye Care

According to references cited by the American Academy of Ophthalmology almost 2.5 Million people in the US suffer from eye injuries each year.


Our patented Nano-Technology electrolytic process enables production of Pure and Stable HClO (Hypoclorous Acid) in a liquid carrier (Bio'n), where all the most important parameters are balanced and optimized in order to obtain one of the best formulation in terms of Efficacy and Safety so maximizing its disinfectant and tissue regenerating properties.


HClO is produced by human immune system as protective agent against infectious pathogens, including bacteria, viruses, yeasts and some fungi and it is also one of the primary driver in any tissue regeneration, wound healing process.


Bio'n is under investigation eye injuries and eye infections, the first tests on the Product showed much promising results.






Search results